Use and Prognostic Implications of Cardiac Troponin in COVID-19

Mostrar otras versiones (1)

Myocardial injury is common in patients with COVID-19 and is associated with an adverse prognosis. Cardiac troponin (cTn) is used to detect myocardial injury and assist with risk stratification in this population. SARS-CoV-2 infection can play a role in the pathogenesis of acute myocardial injury du...

Descripción completa

Detalles Bibliográficos
Autores principales: De Michieli, Laura, Jaffe, Allan S., Sandoval, Yader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968179/
https://www.ncbi.nlm.nih.gov/pubmed/35851452
http://dx.doi.org/10.1016/j.ccl.2022.03.005
Descripción
Sumario:Myocardial injury is common in patients with COVID-19 and is associated with an adverse prognosis. Cardiac troponin (cTn) is used to detect myocardial injury and assist with risk stratification in this population. SARS-CoV-2 infection can play a role in the pathogenesis of acute myocardial injury due to both direct and indirect damage to the cardiovascular system. Despite the initial concerns about an increased incidence of acute myocardial infarction (MI), most cTn increases are related to chronic myocardial injury due to comorbidities and/or acute nonischemic myocardial injury. This review will discuss the latest findings on this topic.

Ejemplares similares